Clinical Trials
9 trialsNCT02373371 2025-07-29
Actinic Keratoses Treatment With Metvix® in Combination With Light
University Hospital, Limoges
Phase 3 Completed
NCT00472459 2025-04-18
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
Phase 3 Completed
NCT00472108 2024-08-05
Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma
Galderma R&D
Phase 3 Completed
NCT01966120 2023-07-28
Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)
Biofrontera Bioscience GmbH
Phase 3 Completed
NCT00306800 2021-02-18
Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
Galderma R&D
Phase 3 Completed
NCT00869635 2014-02-06
S-1 and Photodynamic Therapy in Cholangiocarcinoma
Asan Medical Center
Phase 3 Completed
NCT00926952 2011-09-09
Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion
Innovaderm Research Inc.
Phase 3 Completed
NCT00308854 2008-04-11
Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK
photonamic GmbH & Co. KG
Phase 3 Completed
NCT00308867 2008-04-11
PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK
photonamic GmbH & Co. KG
Phase 3 Completed